← ANALYSTS · TIPRANKS

Li Watsek · Cantor Fitzgerald

#11877among 12,504 TipRanks analysts★★★★★★★★★★
Hits 39% 41 of 105 ratings made money (TipRanks, all the analyst’s ratings)
Average return of a rating −9.1% Over a year after the rating, TipRanks’ measure
Our companies rated now 11 Buy / hold / sell: 11 / 0 / 0
Upside of the analyst’s targets +192.1% Average over 3 current targets, to the last price
The market’s answer to the ratings +2.6% Day-0 move against SPY in the rating’s direction, average over 5 upgrades, downgrades and target changes
Date · added, NYStockAction RatingPrice target Upside Move vs SPY
Sep 25on TipRanks Sep 28 08:30 ASNDAscendis Pharma · $13.9B Reiterated Buy $300 +33.2% −2.8%next day +2.7% · 5 days +1.2%
Aug 21on TipRanks 06:17 NUVBIWMNuvation Bio · $1.7B Initiated Buy $12.00 +169.7% +1.1%next day −2.2% · 5 days −4.4%
Jul 31on TipRanks 05:10 REPLIWMReplimune Group · $1.1B Upgrade Buy — — —
Jul 16on TipRanks Jul 20 04:55 ANLAdlai Nortye Ltd. Sponsored ADR · $701M Reiterated Buy — — +7.3%next day +2.6% · 5 days +18.1%
Jul 8on TipRanks 07:00 IMRXIWMImmuneering · $235M Initiated Buy $17.00 +373.5% +8.7%next day −3.9% · 5 days −8.0%
Jun 3on TipRanks Jun 18 06:06 FTHFaeth Therapeutics · $517M Reiterated Buy — — −0.9%next day +4.4% · 5 days −24.2%
Mar 4on TipRanks Mar 5 01:25 TYRAIWMTyra Bioscience · $1.3B Reiterated Buy — — +6.1%next day −1.5% · 5 days +4.9%
Dec 22on TipRanks 16:25 AVBPIWMArriVent BioPharma, Inc. · $828M Initiated Buy — — −0.8%next day −0.5% · 5 days −9.0%
Dec 3on TipRanks 07:30 CMPXIWMCompass Therapeutics · $158M Initiated Buy — — +0.8%next day +4.9% · 5 days −1.1%
Oct 8on TipRanks 12:30 RCUSIWMArcus Biosciences · $2.9B Reiterated Buy — — +6.7%next day +1.0% · 5 days +13.5%
Oct 2on TipRanks 07:00 CNTXIWMContext Therapeutics · $22M Initiated Buy — — +3.0%next day +10.1% · 5 days +39.9%

Ratings of the stocks the collector reads (the companies of QQQ, SPY, IWM, SMH, SOXL and SOXS and the other US stocks of TipRanks’ feed of new ratings) that it has kept: every new one since 30 September 2026, before that the analyst’s latest rating of each company. Upside is the target over the stock’s last price. The analyst at TipRanks ↗